Koyfin Home > Directory > Health Care > Akcea Therapeutics Inc > EV / EBITDA (ntm)

Akcea Therapeutics Inc EV / EBITDA (ntm) Chart (AKCA)

Akcea Therapeutics Inc annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Akcea Therapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,709m
  • Akcea Therapeutics Inc Price / Book for the quarter ending March 03, 2018 was 9.49
  • Akcea Therapeutics Inc Enterprise Value for the quarter ending March 03, 2018 was $1,449m
View Chart On Koyfin